News
News
Sharecare Inc: Unraveling the Secrets Behind The Massive Buyout Offer From Claritas Capital!
Sharecare, a pioneering digital health company has received a buyout offer from Claritas Capital pricing the company's stock from $1.35...
Read moreDetails
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Active Against Coronaviruses as well as RSV
NanoViricides, Inc. (NYSE Amer.: NNVC) reports that it has filed its Annual Report on Form 10-K for the fiscal year...
Read moreDetails
Stock Market Today: Dow Up 300 Points
The stock market had a solid start to the week with the Dow Jones Industrial Average's gain of 300 points.
Read moreDetails
Microsoft Closes $68.7 Billion Game-Changing Acquisition of Activision Blizzard
In a groundbreaking move that sent ripples through the gaming industry, Microsoft announced its acquisition of Activision Blizzard in January...
Read moreDetails
National Western Life & Prosperity Group’s Mega Deal: The Rationale Behind The $1.9 Billion Merger!
National Western Life Group, a prominent player in the insurance industry, has agreed to get acquired by Prosperity Life Group...
Read moreDetails
US Stocks React to Hotter-Than-Expected Wholesale Inflation Data and Fed Policy Insights
US stocks experienced a loss of momentum as investors grappled with hotter-than-anticipated wholesale inflation data and awaited insights from the...
Read moreDetails
PGT Innovations: A Deep Dive Into The $1.9 Billion Rejection Of Miter’s Deal!
PGT Innovations' board unanimously dismissed Miter's fully-financed offer of $33 per share, deeming it insufficient.
Read moreDetails
Exxon’s $60 Billion Deal for Pioneer Natural Resources: Transforming the Oil and Gas Industry Landscape
Exxon Mobil Corporation, one of the world's leading oil and gas companies, is on the verge of making its most...
Read moreDetails
Volcon ePowersports Secures Financial Boost with Prestige Capital Finance Factoring Agreement
Volcon Inc. (NASDAQ: VLCN) the first all-electric, off-road powersports company, is pleased to announce a financial milestone with the formalization...
Read moreDetails
OKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease (“DED”)
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of inflammatory dry eye disease...
Read moreDetails